It was suggested that the expression of the Y1R gene was increased in response to estrogen treatment by using the MCF-7 cell line, an estrogen receptor-positive human breast cancer cell line, which has been demonstrated to express high-affinity NPY receptors. The gene discussed is ESR1; the disease is breast cancer.